Discovery of a kinome signature predicting sensitivity and resistance to RAF-MAPK pathway inhibitors in melanoma

被引：0
|
作者：
Hilhorst, Riet
Krayem, Mohammed
Van den Berg, Adrienne
Journe, Fabrice
Hovestad-Bijl, Liesbeth
Van den Hooven, Tim
de Wijn, Rik
Aftimos, Philippe
Ghanem, Ghanem
Ruijtenbeek, Rob
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3163
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in Caenorhabditis elegans
    Gorgon, Szymon
    Billing, Ola
    Eriksson, Anna U.
    Hemmingsson, Oskar
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (09): : 2454 - 2462
  • [32] Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
    Ma, Pengfei
    Fu, Yujie
    Chen, Minjiang
    Jing, Ying
    Wu, Jie
    Li, Ke
    Shen, Ying
    Gao, Jian-Xin
    Wang, Mengzhao
    Zhao, Xiaojing
    Zhuang, Guanglei
    THERANOSTICS, 2016, 6 (08): : 1232 - 1243
  • [33] EGFR ACTIVATION CONFERS RESISTANCE TO MAPK PATHWAY INHIBITORS IN GLIOMA
    Zhang, Jie
    Hariono, Sujatmi
    Hashizume, Rintaro
    Fan, Qiwen
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore
    NEURO-ONCOLOGY, 2013, 15 : 31 - 32
  • [34] EGFR ACTIVATION CONFERS RESISTANCE TO MAPK PATHWAY INHIBITORS IN GLIOMA
    Zhang, J.
    Hariono, S.
    Hashizume, R.
    Fan, Q.
    James, C.
    Weiss, W.
    Nicolaides, T.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 20 - 20
  • [35] Modeling clinical resistance to RAF inhibitors in an in vivo melanoma model provides insights into prevention of resistance
    Das Thakur, Meghna
    Salangsang, Fernando
    Pryer, Nancy
    McMahon, Martin
    Stuart, Darrin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [36] AMBRA1 levels predict resistance to MAPK inhibitors in melanoma
    Di Leo, Luca
    Pagliuca, Chiara
    Kishk, Ali
    Rizza, Salvatore
    Tsiavou, Christina
    Pecorari, Chiara
    Dahl, Christina
    Pacheco, Maria Pires
    Tholstrup, Rikke
    Brewer, Jonathan Richard
    Berico, Pietro
    Hernando, Eva
    Cecconi, Francesco
    Ballotti, Robert
    Bertolotto, Corine
    Filomeni, Giuseppe
    Gjerstorff, Morten Frier
    Sauter, Thomas
    Lovat, Penny
    Guldberg, Per
    De Zio, Daniela
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (25)
  • [37] Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
    Thompson, N
    Lyons, J
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (04) : 350 - 356
  • [38] The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors
    Delmas, Audrey
    Cherier, Julia
    Pohorecka, Magdalena
    Medale-Giamarchi, Claire
    Meyer, Nicolas
    Casanova, Anne
    Sordet, Olivier
    Lamant, Laurence
    Savina, Ariel
    Pradines, Anne
    Favre, Gilles
    ONCOTARGET, 2015, 6 (17) : 15250 - 15264
  • [39] Proliferation Arrest in B-Raf Mutant Melanoma Cell Lines upon MAPK Pathway Activation
    Houben, Roland
    Ortmann, Sonja
    Drasche, Astrid
    Troppmair, Jakob
    Herold, Marco J.
    Becker, Juergen C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (02) : 406 - 414
  • [40] Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway
    Benito-Jardon, Lucia
    Diaz-Martinez, Marta
    Arellano-Sanchez, Nohemi
    Vaquero-Morales, Paloma
    Esparis-Ogando, Azucena
    Teixido, Joaquin
    CANCER RESEARCH, 2019, 79 (09) : 2244 - 2256
12345